As of 2025-12-14, the Relative Valuation of Albireo Pharma Inc (ALBO) is (65.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.15 USD, the upside of Albireo Pharma Inc based on Relative Valuation is -248.2%.
The range of the Relative Valuation is (47.54) - (88.63) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 14.0x | 9.6x |
| Forward P/E multiples | 7.5x - 14.8x | 11.1x |
| Fair Price | (47.54) - (88.63) | (65.43) |
| Upside | -207.7% - -300.8% | -248.2% |
| Date | P/E |